Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 219,161 |
|
|||||
| News | - | ||||||
| Day High | 1.10 | Low High |
|||||
| Day Low | 1.06 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Oncolytics Biotech Inc | ONCY | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.01 | 0.93% | 1.09 | 23:00:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.09 | 1.06 | 1.10 | 1.09 | 1.08 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 541 | 219,161 | US$ 1.08 | US$ 236,461 | - | 0.883 - 3.3942 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:47:08 | 17 | US$ 1.07 | USD |
Oncolytics Biotech Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 79.24M | 73.37M | - | 0 | -27.75M | -0.38 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Oncolytics Biotech News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ONCY Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.03 | 1.1201 | 1.0294 | 1.07 | 129,735 | 0.06 | 5.83% |
| 1 Month | 1.07 | 1.29 | 1.01 | 1.11 | 266,438 | 0.02 | 1.87% |
| 3 Months | 1.19 | 1.29 | 0.883 | 1.05 | 377,728 | -0.10 | -8.40% |
| 6 Months | 1.53 | 1.80 | 0.883 | 1.23 | 387,658 | -0.44 | -28.76% |
| 1 Year | 1.12 | 3.3942 | 0.883 | 2.00 | 579,033 | -0.03 | -2.68% |
| 3 Years | 3.03 | 3.3942 | 0.8021 | 1.97 | 350,844 | -1.94 | -64.03% |
| 5 Years | 1.92 | 6.02 | 0.351 | 2.42 | 585,586 | -0.83 | -43.23% |
Oncolytics Biotech Description
| Oncolytics Biotech Inc is a development-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. Its clinical development plan has the approval of its products as quickly as possible and expands its products into commercially valuable new treatment areas as objectives. The company's product pipeline includes Bavencio, Keytruda, Retifanlimab, and Tecentriq. |
